Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 6
Submit an article Journal homepage
2,733
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies

Jan A. Burgera Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
,
Tadeusz Robakb Medical University of Lodz, Copernicus Memorial Hospital, Lodz, PolandORCID Iconhttps://orcid.org/0000-0002-3411-6357View further author information
ORCID Icon,
Fatih Demirkanc Dokuz Eylul University, Izmir, TurkeyView further author information
,
Osnat Baireyd Rabin Medical Center, Petah Tikva, IsraelView further author information
,
Carol Morenoe Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Barcelona, SpainView further author information
,
David Simpsonf BeiGene, San Mateo, CA, USAView further author information
,
Talha Munirg Department of Haematology, St. James’s Hospital, Leeds, United KingdomView further author information
,
Don A. Stevensh Norton Cancer Institute, Louisville, KY, USAView further author information
,
Sandra Daii Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information
,
Leo W. K. Cheungi Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information
,
Kevin Kweii Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information
,
Indu Lali Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information
,
Emily Hsui Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USAView further author information
,
Thomas J. Kippsj University of California San Diego, Moores Cancer Center, La Jolla, CA, USAView further author information
&
Alessandra Tedeschik ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyView further author information
 show all
Pages 1375-1386 | Received 14 Sep 2021, Accepted 13 Dec 2021, Published online: 11 Jan 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.